BiotechTube
Home/Phaim Pharma/Janey Dillon
JD

Janey Dillon

Head of Family Office & Angel Investor Relations

Phaim Pharma

Therapeutic Areas

Autoimmune DiseasesType 1 DiabetesPsoriasisRheumatoid ArthritisMultiple Sclerosis

Phaim Pharma Pipeline

DrugIndicationPhase
AIM Platform (Lead Program)Type 1 DiabetesPhase 1
AIM PlatformPsoriasisPre-clinical

Leadership Team at Phaim Pharma

DN
Dr Nara Daubeney
CEO & Co-Founder
DA
Dr. Annalisa Jenkins
Non-Executive Chairman
PM
Professor Michael Cheung
Non-Executive Director
View full Phaim Pharma profile